Defining the needle in a haystack: A compendium of genomic, pathologic, and clinical characteristics of rare pulmonary tumors.

Autor: Shields MD; Department of Internal Medicine, Division of Hematology/Oncology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine (IUSOM), Indianapolis, IN 46202, USA., Minton KG; Department of Internal Medicine, Division of Hematology/Oncology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine (IUSOM), Indianapolis, IN 46202, USA., Tran M; Department of Pharmacology and Toxicology, IUSOM., Gunderman PR; Department of Radiology, IUSOM., Larsson LG; Department of Pathology, IUSOM., Guo S; Department of Pathology, IUSOM., Kniese CM; Department of Pulmonary Medicine, IUSOM., Wei CX; Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA., Marin-Acevedo JA; Department of Internal Medicine, Division of Hematology/Oncology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine (IUSOM), Indianapolis, IN 46202, USA., Maniar R; Department of Internal Medicine, Division of Hematology/Oncology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine (IUSOM), Indianapolis, IN 46202, USA., Durm GA; Department of Internal Medicine, Division of Hematology/Oncology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine (IUSOM), Indianapolis, IN 46202, USA., He W; Department of Internal Medicine, Division of Hematology/Oncology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine (IUSOM), Indianapolis, IN 46202, USA., Hanna NH; Department of Internal Medicine, Division of Hematology/Oncology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine (IUSOM), Indianapolis, IN 46202, USA. Electronic address: nhanna@iu.edu.

Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Dec 27; Vol. 199, pp. 108035. Date of Electronic Publication: 2024 Dec 27.

Cetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell Carcinoma.

Autor: Marin-Acevedo JA; Medical Oncology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN 46202, USA., Withycombe BM; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA., Kim Y; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL 33612, USA., Brohl AS; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA., Eroglu Z; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA., Markowitz J; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA., Tarhini AA; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA., Tsai KY; Department of Pathology, Division of Dermatopathology, Moffitt Cancer Center, Tampa, FL 33612, USA., Khushalani NI; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA.

Publikováno v: Cancers [Cancers (Basel)] 2023 Jun 14; Vol. 15 (12). Date of Electronic Publication: 2023 Jun 14.

Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer.

Autor: Schlick B; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, 12902 Magnolia Dr, GME Office, Tampa, FL, 33612, USA., Shields MD; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, 12902 Magnolia Dr, GME Office, Tampa, FL, 33612, USA., Marin-Acevedo JA; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, 12902 Magnolia Dr, GME Office, Tampa, FL, 33612, USA., Patel I; Department of Public Health, University of South Florida, 4202 E Fowler Ave, Tampa, FL, 33620, USA., Pellini B; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, 12902 Magnolia Dr, GME Office, Tampa, FL, 33612, USA. Bruna.Pellini@moffitt.org.; Department of Thoracic Oncology, Moffitt Cancer Center and Research Institute, 12902 Magnolia Dr, CSB 6-THOR PROG, Tampa, FL, 33612, USA. Bruna.Pellini@moffitt.org.

Publikováno v: Current treatment options in oncology [Curr Treat Options Oncol] 2022 Aug; Vol. 23 (8), pp. 1104-1120. Date of Electronic Publication: 2022 Jun 18.

Next generation of immune checkpoint inhibitors and beyond.

Autor: Marin-Acevedo JA; Department of Hematology and Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Kimbrough EO; Division of Hematology and Oncology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA., Lou Y; Division of Hematology and Oncology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA. lou.yanyan@mayo.edu.

Publikováno v: Journal of hematology & oncology [J Hematol Oncol] 2021 Mar 19; Vol. 14 (1), pp. 45. Date of Electronic Publication: 2021 Mar 19.

In Reply - Immune Checkpoint Inhibitor-Induced Type 1 Diabetes: An Underestimated Risk.

Autor: Marin-Acevedo JA; Moffitt Cancer Center, Tampa, FL., Chirila RM; Mayo Clinic, Jacksonville, FL., Dronca R; Mayo Clinic, Jacksonville, FL.

Publikováno v: Mayo Clinic proceedings [Mayo Clin Proc] 2020 Mar; Vol. 95 (3), pp. 615.